|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,320 INR | +0.01% |
|
-1.80% | +14.49% |
AstraZeneca Pharma India Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 12,955.26 million compared to INR 10,029.7 million a year ago. Revenue was INR 13,303.29 million compared to INR 10,290.73 million a year ago.
Net income was INR 1,616.09 million compared to INR 992.93 million a year ago. Basic earnings per share from continuing operations was INR 64.6 compared to INR 39.72 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +14.49% | 1.89B | |
| +55.19% | 801B | |
| +47.26% | 631B | |
| -6.09% | 359B | |
| +21.92% | 337B | |
| +18.40% | 245B | |
| +3.64% | 231B | |
| +12.98% | 219B | |
| +10.86% | 171B | |
| -2.78% | 161B |
ASTRAZENECA PHARMA INDIA LIMITED 
